# EDGAR Filing Document

**Accession Number:** 0001579982
**File Stem:** 0000940400-25-002022
**Filing Date:** 2025-9
**Character Count:** 16440
**Document Hash:** 0fedae5fa348031aa723fadbc0f3b1ab
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-002022.hdr.sgml**: 20250923

**ACCESSION NUMBER**: 0000940400-25-002022

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250923

**DATE AS OF CHANGE**: 20250923

**PERIOD START**: 20250731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARK ETF Trust
- **CENTRAL INDEX KEY:** 0001579982

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22883
- **FILM NUMBER:** 251334247

**BUSINESS ADDRESS:**
- **STREET 1:** 155 WEST 19TH STREET, FIFTH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
- **BUSINESS PHONE:** 212.426.7040

**MAIL ADDRESS:**
- **STREET 1:** 155 WEST 19TH STREET, FIFTH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ark ETF Trust
- **DATE OF NAME CHANGE:** 20130624

## Series and Classes Contracts Data

### ARK Genomic Revolution ETF (Series ID: S000042975)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000133119 | ARK Genomic Revolution ETF | ARKG            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ARK ETF Trust

- **b. Investment Company Act file number:** 811-22883

- **c. CIK number of Registrant:** 0001579982

- **d. LEI of Registrant:** 2549000Z0EWMH3U0CQ16

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 200 Central Avenue

  - **City:** St. Petersburg

  - **State:** FL

  - **Foreign country:** US

  - **Zip / Postal Code:** 33701

  - **Telephone number:** 727-810-8160

**Item A.2. Information about the Series.**

- **a. Name of Series:** ARK Genomic Revolution ETF

- **b. EDGAR series identifier (if any):** S000042975

- **c. LEI of Series:** 254900EYF7TANB19PE71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-07-31

- **b. Date as of which information is reported:** 2025-07-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $1020821335.08

**Total Liabilities:** $9018400.48

**Net Assets:** $1011802934.60

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000133119 | -4.88%               | 16.20%               | -1.89%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-57357218.82            | $11518058.28                               |
| Month 2  | $-8224235.79             | $150382855.35                              |
| Month 3  | $-23742821.97            | $1566281.44                                |

### Schedule of Portfolio Investments

| Name                                                     | Title                                                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Regeneron Pharmaceuticals Inc                            | Regeneron Pharmaceuticals Inc                            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     12344 | NS      | $6733158.24   | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of Califor                           | Pacific Biosciences of California Inc                    | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |  11069051 | NS      | $15275290.38  | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                                    | Beam Therapeutics Inc                                    | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2038109 | NS      | $40171128.39  | 3.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                                        | Veeva Systems Inc                                        | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     41481 | NS      | $11788900.20  | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Butterfly Network Inc                                    | Butterfly Network Inc                                    | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   6311052 | NS      | $10791898.92  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                                | Amgen Inc                                                | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     56938 | NS      | $16802403.80  | 1.66%             |  |  |  | No            |                  1 | On Loan: No      |
| 908 Devices Inc                                          | 908 Devices Inc                                          | CUSIP: 65443P102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2194142 | NS      | $14371630.10  | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings                           | Arcturus Therapeutics Holdings Inc                       | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1687747 | NS      | $20607390.87  | 2.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                            | Recursion Pharmaceuticals Inc                            | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |  11519784 | NS      | $68542714.80  | 6.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                                | Intellia Therapeutics Inc                                | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |   2898650 | NS      | $33740286.00  | 3.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                                    | Twist Bioscience Corp                                    | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |   2104061 | NS      | $70633327.77  | 6.98%             |  |  |  | No            |                  1 | On Loan: No      |
| Absci Corp                                               | Absci Corp                                               | CUSIP: 00091E109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |  11735951 | NS      | $33212741.33  | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals Inc                                | Ionis Pharmaceuticals Inc                                | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |    835953 | NS      | $35929259.94  | 3.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Quantum-Si Inc                                           | Quantum-Si Inc                                           | CUSIP: 74765K105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   7833003 | NS      | $11592844.44  | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                                               | CareDx Inc                                               | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |   2064432 | NS      | $25361547.12  | 2.51%             |  |  |  | No            |                  1 | On Loan: No      |
| ATAI Life Sciences NV                                    | ATAI Life Sciences NV                                    | CUSIP: 000000000<br>LEI: 391200Z8UWPJSNBNCA11 | Long             | EC               | CORP              | DE        |   1580022 | NS      | $6478090.20   | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                            | Adaptive Biotechnologies Corp                            | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |   3473458 | NS      | $35568209.92  | 3.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                              | Incyte Corp                                              | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |    150934 | NS      | $11303447.26  | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                               | Natera Inc                                               | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    331309 | NS      | $44282760.94  | 4.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Personalis Inc                                           | Personalis Inc                                           | CUSIP: 71535D106<br>LEI: 549300EZ2NYFK7H0US48 | Long             | EC               | CORP              | US        |   7003386 | NS      | $38378555.28  | 3.79%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                                         | 10X Genomics Inc                                         | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |   3262482 | NS      | $43880382.90  | 4.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                             | Veracyte Inc                                             | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |   1172331 | NS      | $27561501.81  | 2.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences Inc                                  | Caris Life Sciences Inc                                  | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |    189005 | NS      | $5307260.40   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc                                   | Nurix Therapeutics Inc                                   | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1546112 | NS      | $17409221.12  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Cerus Corp                                               | Cerus Corp                                               | CUSIP: 157085101<br>LEI: 254900BIEY9XIDA04Q21 | Long             | EC               | CORP              | US        |   6843829 | NS      | $8760101.12   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States                            | Schrodinger Inc/United States                            | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |   1930624 | NS      | $39249585.92  | 3.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard BioTools Inc                                    | Standard BioTools Inc                                    | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |   3103842 | NS      | $4128109.86   | 0.41%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                                   | CRISPR Therapeutics AG                                   | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |   1892951 | NS      | $106497423.26 | 10.53%            |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                             | Illumina Inc                                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    300126 | NS      | $30825941.46  | 3.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Prime Medicine Inc                                       | Prime Medicine Inc                                       | CUSIP: 74168J101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   4640499 | NS      | $17355466.26  | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                                      | Guardant Health Inc                                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |   1144255 | NS      | $46891569.90  | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Tempus AI Inc                                            | Tempus AI Inc                                            | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |   1572928 | NS      | $89011995.52  | 8.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Pathways Plc                                     | Compass Pathways Plc                                     | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |   2063748 | NS      | $8977303.80   | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                               | Vertex Pharmaceuticals Inc                               | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     23628 | NS      | $10794924.36  | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Financial Square Treasury Obligations Fund | Goldman Sachs Financial Square Treasury Obligations Fund | CUSIP: 38141W323<br>LEI: 549300C0TCI4VJPGCS21 | Long             | STIV             | RF                | US        |   1030828 | NS      | $1030828.35   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-09-23

**Name of Applicant:** ARK ETF Trust

**Signature:** Bill Cox

**Name of Signer:** Bill Cox

**Title:** Principal Financial Officer